Antibodies for carcino-embryonic antigen (CEA)
Company
Zymed Laboratories, Inc.
Use
Marketed as a immunohistochemical research reagent useful for the detection and/or study of various cancers
Features
Does not react with normal colon tissue
NIH Contribution
Developed the ATCC cell line designed Col-1
HHS Institute/Agency
NCI
Inventor(s)
J. Schlom
Year
1992
Tech Cat
Research Reagent
Request More Info
